ClinicalTrials.Veeva

Menu
F

FutureSearch Trials | Dallas, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

EYE103
Solanezumab
CTx-1301
Lurasidone
Galcanezumab
Lasmiditan
Aripiprazole
Vilazodone
Iloperidone
MIN-117

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 13 total trials

A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD) (AMARONE)

EYE103-101 is a 2-part study assessing safety and preliminary efficacy of EYE103 in patients with diabetic macular edema (DME) given as monotherapy o...

Enrolling
Diabetic Macular Edema (DME)
Neovascular Age-related Macular Degeneration (NVAMD)
Drug: EYE103

A Phase 3, randomized, double-blind, placebo-controlled, multi-center, fixed-dose, parallel-group efficacy and safety study in a pediatric population...

Active, not recruiting
Attention Deficit Hyperactivity Disorder Combined
Attention Deficit Hyperactivity Disorder
Drug: CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
Drug: CTx-1301-Dexmethylphenidate 25mg (randomized fixed dose)

Trial sponsors

Lilly logo
Akili Interactive Labs logo
C
E
Forest Laboratories logo
M
M
Novartis logo
Otsuka logo
Sumitomo Pharma logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems